Invention Grant
- Patent Title: Methods for treating atopic dermatitis by administering an IL-4R inhibitor
-
Application No.: US16409164Application Date: 2019-05-10
-
Publication No.: US11292847B2Publication Date: 2022-04-05
- Inventor: Ashish Bansal
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Merchant & Gould, P.C.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06 ; A61P17/00 ; A61K39/00
Abstract:
The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody.
Information query
